β-Amyloid Antibody (6C3): sc-517461

β-Amyloid Antibody (6C3) is a mouse monoclonal IgG2b antibody that detects β-Amyloid in human samples through western blotting (WB). β-Amyloid is a critical peptide derived from the proteolytic cleavage of the Amyloid precursor protein (APP), and accumulation of β-Amyloid is a hallmark of Alzheimer′s disease, as well as being implicated in other neurological disorders and type II diabetes. β-Amyloid formation is particularly significant because β-Amyloid contributes to the development of neurofibrillary tangles and senile plaques, which are pathological features observed in the brains of Alzheimer′s patients. Understanding β-Amyloid structure is essential, as β-Amyloid exists in various forms, including soluble and insoluble aggregates, which can influence neurotoxic properties and interactions with other proteins. Notably, β-Amyloid interacts with several key proteins, including apolipoprotein E (ApoE), which plays a role in lipid metabolism and is also associated with Alzheimer′s disease risk. Anti-β-Amyloid antibody (6C3) specifically targets β-Amyloid, making this antibody an invaluable tool for researchers studying the mechanisms of amyloid pathology and the development of therapeutic strategies aimed at mitigating β-Amyloid accumulation in neurodegenerative diseases.

The preferred β-Amyloid antibody is β-Amyloid Antibody (B-4): sc-28365.